PH13858A - Stabilized thymosin fraction 5 and method for preparing same - Google Patents

Stabilized thymosin fraction 5 and method for preparing same

Info

Publication number
PH13858A
PH13858A PH20803A PH20803A PH13858A PH 13858 A PH13858 A PH 13858A PH 20803 A PH20803 A PH 20803A PH 20803 A PH20803 A PH 20803A PH 13858 A PH13858 A PH 13858A
Authority
PH
Philippines
Prior art keywords
thymosin fraction
preparing same
stabilized
reconstitution
permeate
Prior art date
Application number
PH20803A
Other languages
English (en)
Inventor
H Newmark
W Mcgregor
A Ramel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH13858A publication Critical patent/PH13858A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PH20803A 1977-02-22 1978-02-21 Stabilized thymosin fraction 5 and method for preparing same PH13858A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/770,480 US4082737A (en) 1977-02-22 1977-02-22 Stabilized thymosin composition and method

Publications (1)

Publication Number Publication Date
PH13858A true PH13858A (en) 1980-10-22

Family

ID=25088687

Family Applications (1)

Application Number Title Priority Date Filing Date
PH20803A PH13858A (en) 1977-02-22 1978-02-21 Stabilized thymosin fraction 5 and method for preparing same

Country Status (20)

Country Link
US (1) US4082737A (fr)
JP (1) JPS53104719A (fr)
AT (1) AT363177B (fr)
AU (1) AU516946B2 (fr)
BE (1) BE864139A (fr)
CA (1) CA1099633A (fr)
CH (1) CH632164A5 (fr)
DE (1) DE2807202C2 (fr)
DK (1) DK78378A (fr)
FR (1) FR2380782A1 (fr)
GB (1) GB1546027A (fr)
IE (1) IE46409B1 (fr)
IL (1) IL54063A0 (fr)
IT (1) IT1092337B (fr)
LU (1) LU79090A1 (fr)
NL (1) NL189281C (fr)
NZ (1) NZ186489A (fr)
PH (1) PH13858A (fr)
SE (1) SE444647B (fr)
ZA (1) ZA78890B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732587A1 (de) * 1976-09-22 1978-03-23 Bach Jean Francois Polypeptid mit thymischer wirksamkeit
US4148788A (en) * 1978-01-23 1979-04-10 Hoffmann-La Roche Inc. Synthesis of thymosin α1
US4239498A (en) * 1978-11-27 1980-12-16 Rule Allyn H Method of preparing thymic factors and composition
US4264571A (en) * 1979-01-22 1981-04-28 George Washington University Radioimmunoassay of thymosin α1
WO1982000407A1 (fr) * 1980-08-08 1982-02-18 Sykes A Systeme d'etageres ameliore
US4427783A (en) 1981-12-14 1984-01-24 Hoffmann-La Roche Inc. Immunoassay of thymosin α1
US4389343A (en) * 1981-12-24 1983-06-21 Hoffmann-La Roche Inc. Immunopotentiating peptides from thymus
US4388234A (en) * 1981-12-28 1983-06-14 Hoffmann-La Roche Inc. Peptide isolation
US4614731A (en) * 1983-09-15 1986-09-30 Hoffmann-La Roche Inc. Peptide having immunopotentiating activity similar to thymosin alpha1
US4659694A (en) * 1983-10-27 1987-04-21 Hoffmann-La Roche Inc. Prothymosin alpha
US4814434A (en) * 1984-02-03 1989-03-21 Ventres Laboratories, Inc. Inducer of T-suppressor cells
DE3633651A1 (de) * 1986-10-03 1988-04-14 Alfred Dr Dick Verwendung von fraktionen aus thymus- und milzextrakten zur behandlung der psoriasis
US5273963A (en) * 1991-03-29 1993-12-28 The George Washington University Compositions and methods for treating small cell and nonsmall cell lung cancers
JP4404866B2 (ja) 2006-03-03 2010-01-27 ゼライス株式会社 エンドトキシン含有量を低減したゼラチンの製造方法および低エンドトキシンゼラチン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002602A (en) * 1974-03-11 1977-01-11 Gideon Goldstein Ubiquitous immunopoietic polypeptide (UBIP) and methods
US4010148A (en) * 1975-05-12 1977-03-01 Board Of Regents Of The University Of Texas System Purified thymosin and process
US4002740A (en) * 1975-08-21 1977-01-11 Gideon Goldstein Tridecapeptide compositions and methods

Also Published As

Publication number Publication date
SE7802014L (sv) 1978-08-23
DK78378A (da) 1978-08-23
AU516946B2 (en) 1981-07-02
CA1099633A (fr) 1981-04-21
ATA124578A (de) 1980-12-15
DE2807202C2 (de) 1987-04-02
NL7801422A (nl) 1978-08-24
NZ186489A (en) 1981-01-23
GB1546027A (en) 1979-05-16
JPS53104719A (en) 1978-09-12
BE864139A (fr) 1978-08-21
AT363177B (de) 1981-07-10
IT7819791A0 (it) 1978-01-30
LU79090A1 (fr) 1979-05-25
FR2380782B1 (fr) 1980-01-18
IE780335L (en) 1978-08-22
NL189281B (nl) 1992-10-01
NL189281C (nl) 1993-03-01
CH632164A5 (de) 1982-09-30
IT1092337B (it) 1985-07-06
FR2380782A1 (fr) 1978-09-15
IE46409B1 (en) 1983-06-01
JPS618806B2 (fr) 1986-03-18
DE2807202A1 (de) 1978-08-24
ZA78890B (en) 1979-01-31
AU3334378A (en) 1979-08-23
IL54063A0 (en) 1978-04-30
SE444647B (sv) 1986-04-28
US4082737A (en) 1978-04-04

Similar Documents

Publication Publication Date Title
FR2380782B1 (fr)
DK183386A (da) Sucralfatsuspension
FI820116A7 (fi) Jauhemainen polymeerikoostumus, menetelmä sen valmistamiseksi ja sen käyttö.
SE8402560L (sv) Farmaceutisk komposition
IT1209377B (it) Eteri basici, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.
EP0077377A4 (fr) Compositions de glycoside d'anthracycline, leur utilisation et preparation.
MX6015E (es) Procedimiento para la preparacion de composiciones de globulina de suero inmune,altamente estabilizada
AR240450A1 (es) Excluida su aplicacion en o sobre animales, derivados de acido oxamidico, procedimiento para su preparacion y composiciones parasiticidas que los contienen.
FI830163A7 (fi) Fenyylietyleeni-johdannaisia, niiden valmistus ja käyttö lääkeaineina.
FI801667A7 (fi) Nestemäinen polttoainekoostumus, menetelmä sen valmistamiseksi ja emulgointiaine.
SE413171B (sv) Fergkompositioner for keratinfibrer, i synnerhet for menniskohar, innehallande 3-halogen-6-acetylamino (eller ureido) fenol-kopplingssubstanser
ES505028A0 (es) Sistema indicador perfeccionado para determinar el periodo de utilidad de productos, con liberacion de agentes activos en la atmosfera.
FI853228A7 (fi) Uudet -butyrolaktaamit, niiden farmaseuttisesti aktiiviset koostumukset, menetelmät niiden valmistamiseksi ja niiden käyttö lääkeaineina.
IT8835737V0 (it) Poltrona perfezionata per mezzi di trasporto, in particolare per aeromobili
FI822671A7 (fi) Aminoglykosidijohdannaisia, menetelmiä niiden valmistamiseksi, niitä sisältäviä farmaseuttisia koostumuksia ssekä tällaisia johdannaisia kä ytettäviksi lääkeaineina.
FI843139A7 (fi) Menetelmä dihydrokarbyylikarbonaattien valmistamiseksi, niiden käyttö polttoaineiden lisäaineina ja niitä sisältäviä polttoaineseoksia.
IT8019770A0 (it) Derivati della benzammidina, procedimento per la loro preparazione e composizioni fungicide che li contengono.
NO913502D0 (no) Kompositt for anvendelse som hoeyenergi-sprengstoff eller drivmiddel.
IT7925308A0 (it) Metodo per la crescita di piante, particolarmente piante boschive, e unita' di crescita per l'uso in detto metodo.
Kuzel et al. Mycosis fungoides: time to define the best therapy
IT8721055A0 (it) Derivati prostaglandinici, procedimenti per prepararli e composizioni farmaceutiche che licontengono.
FA et al. Influence of combined effects of bleomycin and X-rays on the growth rate of eat and hela cells
FI852710A7 (fi) Fenyylietyyliaminopropiofenoni -johdannaisia, menetelmiä niiden valmistamiseksi ja näitä sisältäviä lääkeaineita.
IT1170772B (it) Derivati pirazolidinonici dotati di proprieta' anoressiche, formulazioni farmaceutiche che li contengono e procedimento per la loro preparazione
ES243151Y (es) Esmeriladora-satinadora perfeccionada para perfilados de madera, molduras y otras.

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 14